Published Date: 10 Mar 2023
A recent study by Ruifang Zhang and colleagues showed that aminophylline reduced the risk of death and prolonged survival in patients with sepsis. more...
Read Full NewsNew findings from the EMBARK study highlight Elevidys' significant long-term benefits in slowing Duchenne muscular dystrophy progression in young patients.
A study of 614 brain donors revealed that individuals with stage III or IV CTE face the greatest risk of dementia.
FDA Approves First Dual-Agent Eye Drop for Near Vision Loss
1.
As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.
2.
In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.
3.
Highly Successful Treatment of Lynch Syndrome Patients with PD-1 Inhibitors for Colorectal Cancer.
4.
Inadvertent lung cancer screening results are discussed in a new study.
5.
Q&A: When will individuals be able to receive customized cancer vaccines?
1.
Octreotide's Efficacy in Reducing Transfusion Requirements in Angiodysplasia Bleeding
2.
Asymptomatic Thrombocytopenia: Unraveling the Enigma of Low Platelet Counts Without Symptoms
3.
What Is Degos Disease? A Comprehensive Overview Of Symptoms, Diagnosis, and Treatment
4.
What are Acanthocytes? Understanding the Role of Spiky Red Blood Cells
5.
Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Thromboprophylaxis In Medical Settings- An Update
2.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
4.
Thromboprophylaxis In Medical Settings
5.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation